Tag: Vabysmo
Roche: Third indication for Vabysmo in the USA
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Roche: The European Commission has approved vabysmo
(CercleFinance.com) – Roche announced today that the European Commission has approved vabysmo (faricimab) for the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment due to diabetic…
Roche: the European Commission has approved vabysmo
(CercleFinance.com) – Roche announced today that the European Commission has approved vabysmo (faricimab) for the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment due to diabetic…
Roche: Favorable CHMP opinion for Vabysmo
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Roche: positive data around Vabysmo in AMD
(CercleFinance.com) – Roche today presented new two-year data from two studies looking at Vabysmo (faricimab) as a treatment for age-related macular degeneration (AMD), a disease that affects nearly 20 million…
Roche: confirmed treatment comfort for Vabysmo over two years
Zurich (awp) – Roche welcomes the continued advantage of its new ophthalmology treatment Vabysmo (faricimab) over old standards in terms of treatment comfort, at a specialized congress in the United…
Roche: green light from the FDA in the USA for Vabysmo
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…